Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research

The increasing use of genomics to define the pattern of actionable mutations and to test and validate new therapies for individual cancer patients, and the growing application of liquid biopsy to dynamically track tumor evolution and to adapt molecularly targeted therapy according to the emergence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvestris, Nicola, Ciliberto, Gennaro, De Paoli, Paolo, Apolone, Giovanni, Lavitrano, Maria Luisa, Pierotti, Marco A., Stanta, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598055/
https://www.ncbi.nlm.nih.gov/pubmed/28903768
http://dx.doi.org/10.1186/s13046-017-0598-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598055/
https://www.ncbi.nlm.nih.gov/pubmed/28903768
http://dx.doi.org/10.1186/s13046-017-0598-x

Ejemplares similares